Overall AI Rating
0.0%
An average rating. The company shows mixed signals across growth and financial strength.
Sun Pharma.Inds. (SUNPHARMA)
NSE: SUNPHARMAPharmaceuticals & Biotechnology
Hold
AI Scores Summary
Fundamental
3.40 / 5
Future Outlook
1.40 / 5
Technical
2.40 / 5
Combined
2.80 / 5
Combined AI Score
—
The overall score is a weighted combination of fundamental (50%), technical (35%), future outlook (15%).
Market Snapshot
- Market Cap₹ 4,24,886.39 Cr.
- Current Price₹ 1,779.7
- 52W High / Low₹ 2,046.9 / ₹ 1,569.37
- P/E Ratio33.63
- Industry P/E34.87
- Dividend Yield0.90 %
Future Guidance and Outlook
Key updates from management on performance, investments and future growth.
Guidance narrative
Management’s guidance on growth, margins and cash generation.
Management guidance for FY27: expect high single-digit consolidated top-line growth based on current regulatory and macro environment understanding.
Capacity narrative
Investing in people, plants and capabilities to build for the future.
Greenfield sterile facility under development in Madhya Pradesh (sterile-only facility) to add supply capacity for global geographies; intended to address future volume and compliance requirements.
Order pipeline
Deal wins, demand signals and pipeline momentum.
Global Innovative Medicines sales Q4 FY26: US$ 354 million, up 20.1% YoY; full year FY26 US$ 1,420 million, up 16.8% — Innovative Medicines accounted for 22.2% of quarter sales.
Fundamental Analysis
Evaluate financial health & long-term growth potential
Verdict
P/E33.63
Industry P/E34.87
P/E vs Industry0.96x
PEG1.06x
EPS CAGR (5Y)31.64 %
Revenue Rating (3Y)3.00 / 5
Revenue Rating (10Y)2.00 / 5
Net Profit (3Y)3.00 / 5
Net Profit (10Y)3.00 / 5
Balance Sheet4.00 / 5
CFO Growth3.00 / 5
CFO to EBIT4.00 / 5
Technical Analysis
Analyze price trends, momentum & market sentiment
Technical Score2.40 / 5
Verdict
TrendConsolidation
Trend (1Y)Consolidation
DMA SignalBelow both DMAs
DMA 50₹ 1,876.13
DMA 200₹ 1,825.75
RSI33.78
RSI ZoneWeak
Return 1M-6.28 %
Return 3M-6.50 %
Return 6M3.80 %
Momentum Composite-3.84 %
Industry Peers Comparison
Compare SUNPHARMA with its Pharmaceuticals & Biotechnology peers
Next step
You’ve researched SUNPHARMA. Now invest with clarity.
Looking up a specific company is only half the job. Knowing how to invest and when to act is what builds wealth. Invest with InvestVidhi — get research-backed signals, portfolio guidance, and a clear plan so you don’t guess your next move.